UCB SA (OTCMKTS:UCBJY) Increases Dividend to $0.48 Per Share

UCB SA (OTCMKTS:UCBJY - Get Free Report) announced a dividend on Monday, April 21st, investing.com reports. Shareholders of record on Tuesday, April 29th will be given a dividend of 0.4838 per share on Wednesday, May 14th. This represents a yield of 0.62%. The ex-dividend date is Monday, April 28th. This is a 5.8% increase from UCB's previous dividend of $0.46.

UCB Trading Up 2.7 %

Shares of OTCMKTS:UCBJY traded up $2.27 during trading on Friday, reaching $86.43. 29,227 shares of the company traded hands, compared to its average volume of 43,152. UCB has a 52 week low of $63.58 and a 52 week high of $106.60. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.78 and a current ratio of 1.19. The company's 50 day moving average is $90.16 and its two-hundred day moving average is $94.23.

UCB Company Profile

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.